Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study

The combination of intravenous (i.v.) vinorelbine and epirubicin is highly active in the treatment of metastatic breast cancer (MBC). In an effort to improve patient convenience, we investigated a regimen alternating i.v. and oral vinorelbine in combination with epirubicin as first-line chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Serin, D, Verrill, M, Jones, A, Delozier, T, Coleman, R, Kreuser, E-D, Mross, K, Longerey, B, Brandely, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361780/
https://www.ncbi.nlm.nih.gov/pubmed/15928659
http://dx.doi.org/10.1038/sj.bjc.6602588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361780/
https://www.ncbi.nlm.nih.gov/pubmed/15928659
http://dx.doi.org/10.1038/sj.bjc.6602588

Ejemplares similares